TY - JOUR
KW - Adult
KW - Antiviral Agents/administration & dosage/therapeutic use
KW - Connecticut
KW - Direct acting antivirals (DAA)
KW - Female
KW - Harm Reduction
KW - Hepatitis C (HCV)
KW - Hepatitis C/complications/drug therapy
KW - Humans
KW - Male
KW - Opiate Substitution Treatment/methods
KW - Opioid treatment program (OTP)
KW - Opioid-Related Disorders/complications/drug therapy
KW - People who inject drugs (PWID)
KW - Retrospective Studies
KW - Substance Abuse Treatment Centers
KW - Substance Abuse, Intravenous/complications/drug therapy
KW - Substance use disorder (SUD)
KW - Treatment Outcome
AU - J. L. Butner
AU - N. Gupta
AU - C. Fabian
AU - S. Henry
AU - J. M. Shi
AU - J. M. Tetrault
A1 - 
BT - Journal of substance abuse treatment
C5 - Opioids & Substance Use
CY - United States
DO - 10.1016/j.jsat.2016.12.014
JF - Journal of substance abuse treatment
PB - Elsevier Inc
PP - United States
PY - 2017
SN - 1873-6483; 0740-5472
SP - 49
EP - 53
EP - 
T1 - Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program
T2 - Journal of substance abuse treatment
TI - Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program
U1 - Opioids & Substance Use
U2 - 28237054
U3 - 10.1016/j.jsat.2016.12.014
VL - 75
VO - 1873-6483; 0740-5472
Y1 - 2017
ER -